Purchases and Sales Made in Q4 2022 in Regenxbio Inc. (RGNX)
This table provides information about the institutional ownership of Regenxbio Inc. (RGNX) during Q4 2022. The information is specifically focused on institutions that hold shares of REGENXBIO Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 02, 2023
Q4 2022
|
Monarch Partners Asset Management LLC
|
SELL
|
- |
-27.5K- 27.59% |
$560K - $679K
|
72.1K
$573K
|
|
|
Feb 13, 2023
Q4 2022
|
Arch Point Investors
Coral Gables, FL |
SELL
|
- |
-28.4K- 11.22% |
$578K - $701K
|
224K
$1.78M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-34.7K- 5.5% |
$708K - $858K
|
596K
$4.74M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-34.7K- 5.5% |
$708K - $858K
|
596K
$4.74M
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-34.8K- 69.65% |
$709K - $860K
|
15.2K
$120K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-38.1K- 10.95% |
$777K - $942K
|
310K
$2.46M
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-39.7K- 30.83% |
$809K - $981K
|
89K
$708K
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-48.7K- 22.05% |
$994K - $1.21M
|
172K
$1.37M
|
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-59.2K- 12.13% |
$1.21M - $1.46M
|
429K
$3.41M
|
|
|
Feb 14, 2023
Q4 2022
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-70K- 7.23% |
$1.43M - $1.73M
|
898K
$7.14M
|
|
|
May 23, 2023
Q4 2022
|
Royce & Associates LP
|
SELL
|
- |
-101K- 55.29% |
$2.06M - $2.49M
|
81.6K
$649K
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-260K- 6.42% |
$5.31M - $6.43M
|
3.79M
$30.2M
|
|
|
Feb 14, 2023
Q4 2022
|
First Manhattan CO
New York, NY |
SELL
|
- |
-269K- 38.06% |
$5.48M - $6.64M
|
437K
$3.48M
|